Cardiovascular Diseases, Cardiovascular Risk Factor, High Blood Pressure, Hyperglycemia, Hyperlipidemias, Hypertension
Conditions
Keywords
DASH, diet, trial, cardiovascular disease, blood pressure
Brief summary
The DASH diet (Dietary Approaches to Stop Hypertension) have been proven to lower risk of cardiovascular diseases. But the DASH diet is inconsistent with Chinese dietary pattern. In this study, based on the typical Cantonese diet, the healthy Cantonese diet is developed according to the DASH diet and the balanced dietary pattern of the Chinese Dietary Guidelines 2016. The randomized control trial is designed to investigate whether the healthy Cantonese diet has benefit to blood pressure, blood lipid, blood glucose and other cardiometabolic biomarkers among adults with cardiometabolic syndrome in Guangdong, China.
Interventions
OTHERthe healthy Cantonese diet
After a 1-week run-in period, the intervention group will eat the healthy Cantonese diet for 4 consecutive weeks. Free meals will be provided 3 times a day (breakfast, lunch, dinner). The actually intake of every meal for all subjects will be recorded to estimate their nutrients intake. All subjects will be advised to avoid eating other food, but they should inform researchers of what they eat if they eat food that we will not provide.
OTHERthe typical Cantonese diet
After a 1-week run-in period, the control group will still eat the typical Cantonese diet for 4 consecutive weeks. Free meals will be provided 3 times a day (breakfast, lunch, dinner). The actually intake of every meal for all subjects will be recorded to estimate their nutrients intake. All subjects will be advised to avoid eating other food, but they should inform researchers of what they eat if they eat food that we will not provide.
Sponsors
Sun Yat-sen University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
Due to the particularity of dietary intervention studies, it is hard to blind researchers and kitchen staff. Therefore, this trial only blinds subjects. In order to ensure blinding, they will be not told which group they have been assigned and the two groups will eat their assigned diet in different rooms. And outcomes assessors will also be blinded to the two diet groups.
Intervention model description
All subjects will enter 1-week run-in feeding period during which they will eat the control diet. After a 1-week run-in period, subjects will be randomly divided into the intervention group and the control group, stratified by gender. The two groups will eat their assigned diet for 4 consecutive weeks.
Eligibility
Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. Age 25-75 years old, male or female; 2. have lived in this community for the past six months, and have no plans to move out or go out in the next three months; 3. the systolic blood pressure is within 130-159mmHg regardless of medication. 4. maintaining the current medication (mainly drugs for hypertension, diabetes or hyperlipidemia) throughout the research period, with the category and dose unchanged; 5. the number of test meal consumed is no less than 18; 6. community feeding mode: eat a meal at least once a day at the research center (preferably lunch or dinner); or home delivery mode: upload meal pictures for three meals every day, and eat a meal and have physical examination at the research center at least once a week; 7. sign the informed consent form.
Exclusion criteria
1. fasting blood glucose ≥10.0mmol/L; 2. total cholesterol ≥7.2mmol/L; 3. injected inulin within a month; 4. unwilling or unable to change the original dietary pattern, or have special dietary needs (such as vegetarians); 5. alcoholism; 6. BMI ≥30kg/m\^2, or losing weight currently; 7. have acute cardiovascular and cerebrovascular events occurred in the past six months; 8. have a history of chronic kidney disease, intestinal irritation or asthma; 9. women who have been/are preparing for pregnancy or lactation; 10. in combination with other serious diseases such as cancer, chronic heart failure, severe depression or other mental disorders, long-term bedridden or unable to move freely; 11. have a history of common food allergies (eggs, seafood, peanuts, etc.); 12. have undergone gastrointestinal surgery; 13. currently suffering from acute phase of diseases such as respiratory infections, fever, severe diarrhea; 14. have deaf-mutism, dementia, unable to communicate properly.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Metabolic syndrome score | before and after 4-week intervention | Changes of metabolic syndrome score in healthy Cantonese diet compared with changes of typical Cantonese diet. Metabolic syndrome score will be derived by standardizing and then summing the following continuously distributed indices of adiposity (waist circumference) to create a z score: hypertension (the average of systolic blood pressure and diastolic blood pressure); hyperglycaemia (fasting plasma glucose); insulin resistance (fasting insulin); fasting HDL-cholesterol × -1; and fasting triacylglycerol z score. |
| Systolic blood pressure and diastolic blood pressure | before and after 4-week intervention | Changes of systolic blood pressure and diastolic blood pressure in healthy Cantonese diet compared with changes of typical Cantonese diet. Blood pressure will be measured by trained investigator at baseline, week 1, week 2, week 3 and week 4, and systolic blood pressure and diastolic blood pressure will be recorded. |
| Blood lipid profile | before and after 4-week intervention | Changes of blood lipid profile in healthy Cantonese diet compared with changes of typical Cantonese diet. Blood lipid profile (total cholesterol, TC; triglyceride, TG; LDL cholesterol, LDLc; HDL cholesterol, HDLc) will be tested by a validated biomedical analyses laboratory using vein serum at baseline and week 4. |
| Glucose metabolism | before and after 4-week intervention | Changes of glucose metabolism in healthy Cantonese diet compared with changes of typical Cantonese diet. Glucose metabolism (fasting plasma glucose and fasting insulin) will be tested by a validated biomedical analyses laboratory using vein serum at baseline and week 4 and insulin resistance index (HOMA-IR) will be calculated by \[fasting insulin (mU/L) × fasting plasma glucose (mmol/L) \]/22.5. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Inflammatory biomarkers | before and after 4-week intervention | Changes of inflammatory biomarkers in healthy Cantonese diet compared with changes of typical Cantonese diet. Inflammatory biomarkers (CRP in mg/L; Tumor TNF-α and IL-6 in ng/L) will be tested by a validated biomedical analyses laboratory using vein serum at baseline and week 4. |
| Cardiopulmonary function | before and after 4-week intervention | Changes of cardiopulmonary function in healthy Cantonese diet compared with changes of typical Cantonese diet. Cardiopulmonary function will be measured by cardiopulmonary exercise testing using CORTEX MetaLyzer 3B at baseline and week 4. |
| Endothelial function | before and after 4-week intervention | Changes of endothelial function in healthy Cantonese diet compared with changes of typical Cantonese diet. Flow-mediated dilatation (FMD) will be assessed to evaluate endothelial function by using UNEX EF38G at baseline and week 4. |
| Blood biochemical marker | before and after 4-week intervention | Changes of blood biochemical marker in healthy Cantonese diet compared with changes of typical Cantonese diet. Blood biochemical marker (calcium, potassium, sodium, magnesium and phosphorus in mmol/L; uric acid in μmol/L) will be tested by a validated biomedical analyses laboratory using vein serum at baseline and week 4. |
| Body mass index (BMI) | before and after 4-week intervention | Height in meters and weight in kilograms will be combined to report body mass index (BMI) in kg/m\^2. |
| Ratio of waist to hip circumference (WHR) | before and after 4-week intervention | Waist circumference in centimeters and hip circumference in centimeters will be combined to report ratio of waist to hip circumference (WHR). |
| Body composition | before and after 4-week intervention | Changes of body composition in healthy Cantonese diet compared with changes of typical Cantonese diet. Body composition will be tested by using dual energy X-ray absorptiometry at baseline and week 4. |
| Urinary sodium and potassium | before and after 4-week intervention | Changes of urinary sodium and potassium in healthy Cantonese diet compared with changes of typical Cantonese diet. Urinary sodium and potassium will be tested by a validated biomedical analyses laboratory using morning urine at baseline and week 4. |
| Intestinal microbiota composition | before and after 4-week intervention | Changes of intestinal microbiota composition in healthy Cantonese diet compared with changes of typical Cantonese diet. |
| Gut microbial gene richness | before and after 4-week intervention | Changes of gut microbial gene richness in healthy Cantonese diet compared with changes of typical Cantonese diet. |
Contacts
Primary ContactHuilian Zhu, professor
Backup ContactAiping Fang
Outcome results
None listed